Clinical Trial Update: Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma [EARLY_Phase 1]

View source ↗

Summary

A single-arm, open-label Phase 1 study evaluating SZ011 for ovarian epithelial carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Epithelial Carcinoma

Drugs mentioned

• SZ011

Snippet

Sponsor: Shantou University Medical College | Conditions: Ovarian Epithelial Carcinoma | EARLY_Phase 1 | Status: RECRUITING